Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11336394 | 0.80 | CA1 (0.31) | — | |
| SCHEMBL25756691 | 0.80 | CA1 (0.31) | — | |
| SCHEMBL12667054 | 0.78 | CHRM2 (0.32) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL26040434 | 0.77 | RIPK1 (0.39) | — | |
| SCHEMBL8015117 | 0.76 | F2 (0.34) | — | |
| SCHEMBL20706556 | 0.75 | CHRM2 (0.33) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL14672587 | 0.75 | CA1 (0.31) | — | |
| SCHEMBL29921319 | 0.74 | — | — | |
| SCHEMBL3974868 | 0.74 | — | — | |
| SCHEMBL31211614 | 0.74 | FAAH (0.36) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2442397-B1 | ELECTROLYTIC SOLUTION AND LITHIUM-ION SECONDARY BATTERY UTILIZING THE SAME | ASAHI CHEMICAL IND (JP) | 2016-10-05 | — | — | EP | disclosed |
| US-9118088-B2 | Electrolyte solution and lithium ion secondary battery using the same | ASAHI KASEI E-MATERIALS CORPORATION (JP) | 2015-08-25 | — | — | US | disclosed |
| US-8808961-B2 | Composition, resist film, pattern forming method, and inkjet recording method | FUJIFILM CORPORATION (JP) | 2014-08-19 | — | — | US | disclosed |
| US-8481722-B2 | High stability polyionic liquid salts | SIGMA-ALDRICH CO. LLC (US) | 2013-07-09 | — | — | US | disclosed |
| US-20120141878-A1 | ELECTROLYTE SOLUTION AND LITHIUM ION SECONDARY BATTERY USING THE SAME | ASAHI KASEI E-MATERIALS CORPORATION (JP) | 2012-06-07 | — | — | US | disclosed |
| EP-2442397-A1 | ELECTROLYTIC SOLUTION AND LITHIUM ION SECONDARY BATTERY UTILIZING SAME | Asahi Kasei E-Materials Corporation (JP) | 2012-04-18 | — | — | EP | disclosed |
| US-20110102528-A1 | COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110102528-A1 | COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND INKJET RECORDING METHOD | ARFGAP1, FRG1, RHOA | CHRM2 3791/4885CHRM4 4254/4885CHRM5 3352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.